A detailed history of Kennedy Capital Management, Inc. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 87,348 shares of MRVI stock, worth $725,861. This represents 0.01% of its overall portfolio holdings.

Number of Shares
87,348
Previous 97,277 10.21%
Holding current value
$725,861
Previous $843,000 25.86%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$6.87 - $11.34 $68,212 - $112,594
-9,929 Reduced 10.21%
87,348 $625,000
Q1 2024

May 15, 2024

SELL
$5.11 - $8.76 $37,139 - $63,667
-7,268 Reduced 6.95%
97,277 $843,000
Q4 2023

Feb 14, 2024

SELL
$4.7 - $9.87 $770 - $1,618
-164 Reduced 0.16%
104,545 $684,000
Q3 2023

Nov 14, 2023

BUY
$9.14 - $12.85 $957,040 - $1.35 Million
104,709 New
104,709 $1.05 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $1.09B
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.